Preventive and therapeutic approaches to short- and long-term sun damaged skin

Clinics in Dermatology

Volumn 16, Issue 4, 1998, Pages 429-439

  Rapaport, Marvin J ^a   Rapaport, Vicki ^a  

^a UCLA MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2 HYDROXYACID; ACETYLSALICYLIC ACID; ANESTHETIC AGENT; CORTICOSTEROID; INDOMETACIN; RETINOID; SALICYLIC ACID DERIVATIVE; SUNSCREEN;

CLINICAL TRIAL; CORTICOSTEROID THERAPY; DRUG FORMULATION; FLUID THERAPY; HUMAN; LENTIGINOSIS; LIGHT DAMAGE; MELANOMA; PRIORITY JOURNAL; REVIEW; SKIN ALLERGY; SKIN DEFECT; SUN EXPOSURE; SUNBURN; SUNLIGHT PROTECTION;

CHILD; HEALTH BEHAVIOR; HUMANS; SKIN AGING; SKIN DISEASES; SKIN NEOPLASMS; SKIN PIGMENTATION; SUNBURN; SUNLIGHT; SUNSCREENING AGENTS; ULTRAVIOLET RAYS;

EID: 0032323959     PISSN: 0738081X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0738-081X(98)00016-9     Document Type: Review

References (64)

1. Czeisler C.A., Johnson M.P., Duffy J.F., et al. Exposure to bright light and darkness to treat physiologic maladaption to night work. New Engl J Med. 322:1990;1253-1259.
2. Leww A.J., Kern H.A., Rosenthal N.E., et al. Bright artificial light treatment of a manic depressive patient with seasonal mood cycle. Am J Psychiatry. 139:1982;1496.
3. Bernard J.D., Juenicke K., Khosrow Momtaz T., et al. Ultraviolet A phototherapy in the prophylaxis of solar urticaria. J Am Acad Dermatol. 10:1984;29-32.
4. Fitzpatrick T.B., Gonzalez E., Bernhard J.D., Johnson R.A. Polymorphous light eruption A perspective . Dermatologic Capsule & Comment. 13:1991;1-5.
5. Wurtman RJ. The effects of light on the human body. Scientific American (January 1989);68-75.
6. Edelson R.L. Light-activated drugs. Scientific American. August:1988;68-75.
7. Unna P.G. Diehistopathologie der Hautrankheiten. 1984;A Hirshwald, Berlin.
8. Blum H.F. Carcinogenesis by ultraviolet light An essay in quantitative biology . 1959;Princeton University Press, Princeton.
9. Forbes P.D., Davies R.E., Cole C.A. Experimental ultraviolet photocarcinogenesis wavelengths, interactions and time-dose relationships . Nat Can Instit Monograph. 50:1978;31-38.
10. Wulf H.N., Poulsen T., Brodthagen H., Hou-Jensen K. Sunscreens for delay of ultraviolet induction of skin tumors. J Am Acad Dermatol. 7:1982;194-203.
11. Pathak M.A. Sunscreen Progress and perspectives on photoprotection of human skin against UVB and UVA radiation . J Dermatol. 23:1996;783-800.
12. Gilcrest B.A., Sazbo G., Flynn E., et al. Chronologic and actinically induced aging in human facial skin. J Invest Dermatol. 80:(Suppl):1983;81-85.
13. The $1,000,000,000 industry. Looking Fit. 7:1992;56-70.
14. DeLeo V.A. Tanning salons. Proceedings of the National Conference on Environmental Hazards to the Skin, October, 1992. 1994;37-42 American Academy of Dermatology, Schaumberg, IL.
15. Spencer J.M., Amonette R.A. Indoor tanning Risks, benefits, and future trends . J Am Acad Dermatol. 33:1995;288-297.
16. Gies H.P., Roy R., Elliott G. Artificial suntanning spectral irradiance and hazard evaluation of ultraviolet sources . Health Physics. 50:1986;691-703.
17. Dinehart S.M., Dodge R., Stanley W.E., et al. Basal cell carcinoma treated with Mohs surgery. J Dermatol Surg Oncol. 18:1992;560-566.
18. Jones S.K., Moseley H., MacKie R.M. UVA induced melanocytic lesion. Br J Dermatol. 117:1987;111-115.
19. Kligman L.H., Kligman A.M. Reflections on heat. Br J Dermatol. 110:1984;369-375.
20. Taylor U., West S., Rosenthal F., et al. Effect of ultraviolet radiation on cataract formation. New Engl J Med. 319:1988;1429-1433.
21. Braida D., Dubeif C., Lang G. Photoageing [sic] of hair fiber and photoprotection. Skin Pharmacol. 7:1994;73-77.
22. Gilcrest B.A., Soter N., Stoff J., et al. The human sunburn reaction. J Amer Acad Dermatol. 5:1981;411-422.
23. Lew R.A., Sober A.J., Cook N., et al. Sun exposure habits in patients with cutaneous melanoma A case control study . J Dermatol Surg Oncol. 9:1983;981-986.
24. Holman C.D., Armstrong B.K. Cutaneous malignant melanoma and indicators of total accumulated exposure to the sun An analysis separating histogenetic types . JNCI. 73:1984;75-82.
25. Naylor M.F. Erythema, skin cancer risks and sunscreens. Arch Dermatol. 133:1997;373-375.
26. Leach J. Sunburn Effects of managements . Pediatrics in Review. 1:1983;13-18.
27. Kaidbey K.H., Kurban A.K. The influence of corticosteroids and topical indomethacin on sunburn erythema. J Invest Dermatol. 66:1976;153-156.
28. Gallagher C.H., Greenoak G.E., Reev V.E., et al. Ultraviolet carcinogenesis in the hairless mouse skin Influence of the sunscreen 2-ethylhexl-p-methoxycinnamate . Aust J Exp Biol Med Sci. 62:1984;577-588.
29. Bernstein E.F., Brown D.B., Tsunemichi T., Kong S.K., Uitto J. Evaluation of sunscreens with various sun protection factors in a new transgenic mouse model of cutaneous photoaging that measures elastin promoter activation. J Am Acad Dermatol. 37:1997;725-729.
30. Marks R., Rennie G., Selwood T.S. Malignant transformation of solar keratoses to squamous cell carcinoma. Lancet. 1:1988;795-797.
31. Lowe N.J., Breeding J. Evaluation of sunscreen protection by measurement of epidermal DNA synthesis. J Invest Dermatol. 74:1980;181-182.
32. Freeman S.E., Ley R.D., Ley K.D. Sunscreen protection against UV-induced pyrimidine dimers in DNA of human skin in situ. Photodermatology. 5:1988;243-247.
33. Whitmore S.E., Morison W.L. Prevention of UVB-induced immunosuppression in humans by a high sun protection factor sunscreen. Arch Dermato. 131:1995;1128-1133.
34. Naylor M.F., Boyd A., Smith D.W., et al. High sun protection factor (SPF) sunscreens in the suppression of actinic neoplasia. Arch Dermatol. 131:1995;170-175.
35. Kligman L.H., Kligman A.M. The nature of photoaging Its prevention and repair . Photodermatology. 3:1986;215-227.
36. Thompson, SC, Jolley D, Marks R. Reduction of solar keratoses by regular sunscreen use. N Eng J Med 1993;329:1147-51.S.
37. Naylor M.F., Farmer K.C. The case for sunscreens. Arch Dermatol. 133:1997;1146-1154.
38. Prosperio G. Natural sunscreens Vegetable derivatives as sunscreens and tanning agents . Cosmetics and Toiletries. 91:1976;38-46.
39. de Fine Olivarius F., Wulf H.C., Crosby J., Norval M. The sunscreening effect of urocanic acid. Photoderm Photoimmun and Photomed. 12:1996;95-99.
40. Sayre R.M., Kollias N., Roberts R., et al. Physical sunscreens. J Soc Cosmet Chem. 41:1990;103-109.
41. Davis S., Capjack L., Kerr N., et al. Clothing as protection from ultraviolet radiation Which fabric is most effective? Internat J Dermatol. 36:1997;374-379.
42. Rapaport M.J. Dermatologic rounds. Dermatology. May:1982;33-48.
43. Groves G.A. The selection and evaluation of ultraviolet absorbers. Australian J Dermatol. 14:1973;21-34.
44. Stenberg C., Larko O. Sunscreen application and its importance for the sun protection factor. Arch Dermatol. 121:1985;1400-1402.
45. FDA Sunscreen drug products for over-the-counter human use. Federal Register. 43:1978;38206-38269.
46. Jones P. Protecting the consumer from getting burned. Tentative final monograph on over the counter sunscreens. Amer J of Law and Medicine. 20:1994;317-335.
47. Gupta A.K., Haberman H., Pawlowski D., et al. Canthaxanthin. Int J Dermatol. 24:1985;528-532.
48. Black H.S. Systemic photoprotective agents. Photodermatol. 4:1987;187-195.
49. Werninghaus K., Meydan M., Bhuwan J., et al. Evaluation of the photoprotective effect of oral vitamin E supplementation. Arch Dermatol. 130:1994;1257-1261.
50. Wolf C., Steiner A., Honingsmann H. Do oral carotenoids protect human skin against ultraviolet erythema, psoralen phototoxicity, and ultraviolet-induced DNA damage? Soc Invest Dermatol. 88:1988;55-57.
51. Levine N., Sheftel S.C., Eythan T., et al. Induction of skin tanning by subcutaneous administration of a potent synthetic melanotropin. JAMA. 266:1991;2730-2736.
52. Hurwitz S. The sun and sunscreen protection Recommendations for children . J Dermatol Surg Oncol. 14:1988;657-660.
53. Stern R.S., Weinstein M.C., Baker S.G. Risk reduction for nonmelanoma skin cancer with childhood sunscreen use. Arch Dermatol. 122:1986;537-545.
54. Knowland J., McKenzie E.A., McHugh P.J., Cridland N.A. Sunlight-induced mutagenicty of a common sunscreen ingredient. FEBS Lett. 324:1993;309-313.
55. Jori G., Spikes J. Photochemistry of prophorins. Smith K. Topics in photomedicine. 1984;183 Plemun Press, New York.
56. Frampton R.J., Osmond S.A., Eisman J.A. Inhibition of human cancer cell growth by 1,25-dihydroxyvitmin D metabolites. Cancer Research. 43:1983;443-447.
57. Kripke M.L. Immunologic mechanisms in UV radiation carcinogenesis. Adv Cancer Research. 34:1981;69-106.
58. Westerdahl J., Olsson A., Masback C., Jonsson I., Jonsson N. Is the use of sunscreens a risk factor for melanoma? Melanoma Research. 5:1995;59-65.
59. Roberts L.K., Stanfield J.W. Letter to the editors; Suggestion that sunscreen use is a melanoma risk factor is based on non-conclusive evidence. Melanoma Research. 5:1995;377-377.
60. Freeman S., Frederiksen. Sunscreen allergy. Amer J Contact Dermatitis. 1:1990;240-243.
61. Thune P. Contact and photocontact allergy to sunscreens. Photodermatol. 1:1984;5-9.
62. Dromgoole S.H., Maibach H.I. Sunscreening agent intolerance Contact and photocontact sensitization and contact urticaria . JAMA Dermatol. 22:1990;1068-1078.
63. Gasparro F. PABA Friend or foe? Photodermatol. 3:1986;61-63.
64. Food and Drug Administration. Department of Health and Human Services. Comment No. APE00004, Docket No. 78N-0038, Dockets Management Branch Commun.